Journal of Clinical Psychopharmacology

Article	Citations
The Treatment of Iatrogenic Anorgasmia in a Male Patient on Clozapine for Treatment-Resistant Schizophrenia	41
Beneficial Effect of Quetiapine on Sleep, Anxiety, Depression and Myalgia Symptoms in a Patient With Post–COVID-19 Condition	39
Comparison of Weight-Based Valproic Acid Dosing in Treatment of Mental Illness Among Obese and Nonobese Patients	27
Transitioning From a Standard Low-Dose to a Rapid Low-Dose Buprenorphine Initiation in a Hospital Setting—A Case Report	27
Plasma Concentrations of Tranylcypromine in Depressed Patients With Chronic Kidney Disease	26
Author Index 2022	25
Better Approaches to Derisking Psychiatric Drug Development are Needed, Not New Funding Mechanisms	23
Possibly Misleading Pharmaceutical Advertising On TV	20
Postinjection Syndrome After Paliperidone?	20
Dysphagia to Liquids Only Associated With Olanzapine	18
Treatment of Cannabis Hyperemesis Syndrome Using Haloperidol in a Pregnant Patient	17
Erratum: What Is the Current State of Evidence Regarding Any Mood-Improving Properties of GLP-1 Receptor Agonists, and Are Psychiatrists Prescribing Them?	16
Pharmacokinetic-Interactions of BI 425809, a Novel Glycine Transporter 1 Inhibitor, With Cytochrome P450 and P-Glycoprotein Substrates	16
The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience	15
Polypharmacy Among Patients With Major Depressive Disorder and Co-occurring Substance Use Disorders in a Psychiatric Hospital Setting	15
Trazodone and Mianserin for Delirium	15
Question	15
Clozapine Use Among Individuals With Schizophrenia Occurring on the Background of Intellectual Disability and Rare Genetic Variation	14
Risperidone-Induced Priapism	14
Clozapine-Associated Myocarditis in a Patient With Poor Metabolism During Fast Titration	14
Hodgkin Lymphoma in Patients Receiving Clozapine Treatment	14
Valbenazine, Fluphenazine, and Possible Neuroleptic Malignant Syndrome in a 58-Year-Old Woman	14
Impact of Adjuvant GLP-1RA Treatment on the Adherence of Second-Generation Antipsychotics in Nondiabetic Adults	14
Mirtazapine as a Treatment for Adolescent Depression and PTSD in Juvenile Detention Settings	13
Duloxetine-Associated Erosive Gastritis and Gastroesophageal Reflux	12

Escitalopram-Associated Drug Rash	12
Thoughts on the Value of Case Series in the Literature	12
Celebrating 70 Years of the First Publication on Antipsychotic Treatment in North America by Heinz E. Lehmann and Gorman E. Hanrahan: Would Their Methodology Still Be Conceivable?	12
Suicidal Ideation and Self-harming Thoughts With Valbenazine Use	12
Postpartum Depression and Antibiotics Overuse in Pakistan: Exploring a Potential Nexus	12
Zopiclone Discontinuation–Associated Transient Sleepwalking Behavior	12
Drug-Associated Liver Injury Related to Antipsychotics	11
Recognition of Clozapine-Associated Eosinopenia in Patients With Treatment-Resistant Schizophrenia	11
The Cardiac Cost of Lithium	11
Effect of Valproate Coprescription on Clozapine Pharmacokinetics in Clinical Practice	11
Pharmacological Treatment and Cognition in Bipolar I Disorder	11
Drug Interaction Between Clozapine and Rifampicin	11
Atomoxetine as a Viable ADHD Treatment in Breastfeeding Mothers	10
Restless Legs Syndrome Associated With Brexpiprazole	10
Treatment of Acute Intermittent Porphyria–Associated Anxiety Disorder With Gabapentin	10
Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations and the Clozapine/Norclozapine Ratio	10
Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders	9
Mood Swings and Irritability in a Patient With Cystic Fibrosis on Elexacaftor-Tezacaftor-Ivacaftor Therapy	9
Neuroleptic Malignant Syndrome Associated With Lurasidone	9
Effect of Cigarette Smoking on Clozapine Dose and on Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice: Erratum	9
SALUTE TO OUR REVIEWERS	9
Clinical and Demographic Predictors of Early Clozapine Discontinuation Across Mood and Psychotic Disorders	9
Betamethasone-Associated Psychosis in a Pregnant Woman Diagnosed With Schizophrenia	9
Clozapine for Severe Irritability in Children and Adolescents With Autism Spectrum Disorder	8
A Case of Akathisia After Administration of a Very Low Dose of Mirtazapine	8
Question	8
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104	8
Successful Treatment of Inappropriate Sexual Behavior and Disinhibition in Dementia With Paroxetine	8
Letter to the Editors in Response to: Flanagan RJ, Hunter S, Obee S, Reeves S. Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets	8
Fluvoxamine Augmentation of Clozapine and Dose-dependent Interaction Patterns	8
Use of Risperidone Long-Acting Injection in the Treatment of Anorexia Nervosa: A Case Report	8
Long-Term Course of Illness With Rapid-Cycling Bipolar Disorder	8
Journal of Clinical Psychopharmacology Updates	8
Severe Panic Disorder After Vaccination With the Pfizer-BioNTech Vaccine	8
Successful Management of ECT-Resistant Interictal Psychosis With Clozapine	8
Postinjection Delirium/Sedation Syndrome After Paliperidone Palmitate Injection in a Bipolar Affective Disorder Patient	7
The Clinical and Economic Burden of Tardive Dyskinesia in Israel	7
Question	7
Oculogyric Crisis Associated With Clozapine: Case Report and Review of Literature	7
Haloperidol-Induced Brugada-Pattern Electrocardiogram—A Case Report and a Review of the Literature	7
Improvement of Compulsive Shopping on Tirzepatide	7
Olanzapine-Associated Hyperbilirubinemia in an Adolescent With Autistic Spectrum Disorder Comorbid With Schizophrenia	7
Clozapine- and Lithium-Associated Myoclonus	7
Mania-Like Reaction Secondary to Sodium Oxybate	7
Safety of Intranasal Esketamine Administration in Brugada Syndrome	7
A Withdrawal Syndrome After a Switch of Phenibut to Another γ-Aminobutyric Acid Agonist	7
Incorporating Real-World Treatment Data Into Clozapine's Product Label	7
Alpha Lipoic Acid for Schizophrenia	6
Use of Clozapine in Pregnancy	6
Use of Sublingual Atropine Drops in Clozapine-Associated Sialorrhea in an Adolescent Patient	6

A System for Rapidly Yet Rigorously Evaluating the Quality of Randomized Controlled Trials	6
Limitations in Recent Study of Clozapine Use During Pregnancy	6
Resolution of Catatonia With Cariprazine—A Case Report	6
CYP2D6 Phenotype as a Predictor of Adverse Drug Reactions in Patients Treated With Trazodone	6
Mania Associated With Cariprazine	6
Plasma Clozapine in Treatment Refractory Schizophrenia	6
Clozapine-Associated Agranulocytosis	6
Pharmacokinetics of Ketamine Transfer Into Human Milk	6
Clozapine Use in Down Syndrome	5
Fixed-Dose Brexpiprazole and Sertraline Combination Therapy for the Treatment of Posttraumatic Stress Disorder	5
Malignant Catatonia and Neuroleptic Malignant Syndrome Overlap in the Emergency Department	5
Liraglutide in Obese or Overweight Individuals With Stable Bipolar Disorder	5
Impact of Selective Serotonin-Reuptake Inhibitors in Hemorrhagic Risk in Anticoagulated Patients Taking Non–Vitamin K Antagonist Anticoagulants	5
Clozapine Associated Periorbital Edema in First Episode Psychosis	5
Therapeutic Drug Monitoring of Paliperidone in Patients With Schizophrenia in Taiwan	5
Author Index 2024	5
Lithium-Associated Nephrogenic Diabetes Insipidus or Catatonic Stereotypical Drinking?	5
Valproic Acid–Associated Hyperammonemia	5
Aripiprazole-Associated QT Prolongation in a Healthy Study Volunteer	5
The Association Between Mood Stabilizers, Sleep Quality, and Functioning in Patients With Remitted Bipolar Disorder	5
Piracetam for Risperidone-associated Hypersalivation	5
Subject Index 2022	5
Atomoxetine Associated Activation Syndrome in Adolescent Patients With ADHD	5
Sleep Quality After Quetiapine Augmentation in Patients With Treatment-Resistant Depression and Personality Disorders	5
Factors Predicting the Efficacy of Valbenazine and Exacerbation of Tardive Dyskinesia After Valbenazine Discontinuation in Japanese Patients	4
At Last, a Nondopaminergic Agent for the Treatment of Schizophrenia: The Combination of Xanomeline and Trospium (Cobenfy)	4
Clozapine-associated Retrograde Ejaculation	4
Clonidine and Trihexyphenidyl in Clozapine-induced Hypersalivation	4
Characterization of Extended-Release Lorazepam	4
A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants	4
Prophylactic Management of Women With Bipolar Disorder During Pregnancy and the Perinatal Period	4
Improving Result Turnaround Time as a Crucial Factor to Increasing Clozapine Therapeutic Drug Monitoring in Hospitalized Patients	4
Seizure, Rhabdomyolysis, and Hypoglycemia in a Patient With Venlafaxine Poisoning	4
Protracted Psychiatric Complications Including Psychosis in a Middle-Aged Man After COVID-19 Vaccination	4
Neurotoxicity Related to Multidrug Association: A Case Report	4
Exploring the Addictive Potential of Tranylcypromine	4
The Potential Role of Fluvoxamine in Clozapine-Associated Constipation	4
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use	4
Question	4
Esketamine for Unipolar Major Depression With Psychotic Features	4
Article Selected to Receive the Mitchell B. Balter Award for 2022	4
Concentrations of Fluoxetine Enantiomers Decline During Pregnancy and Increase After Birth	4
Comparison of Psychiatric and Clinical Profiles Between People Who Use Synthetic Cathinones and Methamphetamine	4
Efficacy of Brexpiprazole Combination Therapy on Anhedonia in a Case of Treatment Resistant Bipolar II Depression	4
You Shall Not Turn a Blind Eye to Intraocular Pressure	4
Human Abuse Potential of Single Oral Doses of Sunobinop, a Novel, Highly Potent, and Selective Partial Agonist for Nociceptin/Orphanin-FQ Peptide (NOP) Receptors	4
Lumbosacral Plexopathy in Clozapine Overdose: A Case Report	4
Differentiating Depressive Symptoms From Side Effects in Individuals With Major Depressive Disorder With Postpartum Onset	4
Reversible Valproic Acid–Associated Cerebral Pseudoatrophy in a 53-Year-Old Male With Bipolar I Disorder	4
Combination of Long-Acting Injectable Antipsychotics in the Treatment of Psychiatric Disorders—A Systematic Review of the Literature and Case Series	4
Hematological and Other Cancers in People Using Clozapine	4
Reply: Misidentified Dopamine Agonists Undermine Investigation Into Aripiprazole Link With Impulse Control Disorders	4
Positive Pyramidal Sign as an Unexpected Presentation in Antipsychotic-Induced Acute Dystonia	4
Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty	4
The Potential Benefits of Chromium and Selenium Supplementation Across Psychiatric Disorders and Symptoms	4
Methylphenidate-Associated Syncope	4
Detecting Anxious Distress, an Important Mood Specifier	4
The Need for Non-profit Psychiatric Drug Discovery and Development	4
Myoclonic Movements and Catatonic-Like Symptoms After Abrupt Cessation of Clozapine	4
Response to Letter to the Editors From Prof D. Taylor	4
A Case of Acute Conditioned Dyspnea During Tracheostomy Weaning Treated Successfully With Adjunctive Mirtazapine	3
Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets	3
Premature Ejaculation After Discontinuation of Venlafaxine in a Case of Bipolar Depression	3
Ketamine as a Potential Neuromodulatory Treatment for Long COVID Neuropsychiatric and Neuropathic Symptoms	3
Imipramine	3
Ischemic Priapism With Therapeutic Serum Concentrations of Psychotropic Medications	3
High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder	3
Health Alert: Microdose Products Leading to Acute Illness and Hospitalizations Across the United States	3
Preventive Effects of Ramelteon, Suvorexant, and Lemborexant on Delirium in Hospitalized Patients With Physical Disease	3
Journal of Clinical Psychopharmacology Updates	3
A Potential Drug-Gene-Drug Interaction Between Cannabidiol, CYP2D6*4, and Fluoxetine	3
How Does Drug Company Marketing Affect Physician Prescribing?	3
REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants	3
The Management of Very Early-Onset Schizophrenia With an Olanzapine and Amisulpride Combination	3
Reply to “Xanomeline/Trospium Combination: Not Non-dopaminergic but a Novel Antidopaminergic Treatment for Schizophrenia”	3
New Onset of Seizures and Psychosis in a Patient Who Is Coprescribed Atomoxetine and Bupropion	3
Panic Disorder Seeks More Specific Drugs for Treatment	3
Evaluating the Quality of Randomized Controlled Trials	3
Toward Precision Psychiatry	3
Efficacy of Low-Dose Adjunctive Methylphenidate Extended-Release on Cognition and Functioning in Individuals With Schizophrenia	3

Venlafaxine-Associated Rhabdomyolysis	3
Toxidrome of an Easily Obtainable Nootropic	3
Ketamine and Esketamine for Depression in Daily Practice	3
Managing a Treatment-Resistant Schizophrenia Spectrum Disorder With a Hormonal Twist in a Female Patient	3
Impact of Prior Psychiatric Diagnoses on the Incidence of Dissociative Symptoms Associated With Analgesic Ketamine Infusions in a Surgical Intensive Care Unit	3
Global Insights Into Antipsychotic Research	3
Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia	3
Semaglutide Misuse in Atypical Anorexia Nervosa—A Case Report	3
A Review of Evidence and an Algorithm for Use of Psychopharmacology in the Treatment of Tobacco Use Disorder in Behavioral Health Settings	3
Neutropenia Associated With Trazodone	3
Relapse of Tardive Dyskinesia Following Successful Treatment With Amantadine	3
Journal of Clinical Psychopharmacology Updates	3
A First Trimester Exposure to Ketamine and Esketamine for Depression	3
α-PVP Associated Psychosis	3
Severe Alprazolam Withdrawal With Delirium and Psychosis	3
Phase 2b Trial of the PDE10A Inhibitor MK-8189 in People With an Acute Episode of Schizophrenia	3
Assessing Adherence to Clozapine	3
Adolescent Aripiprazole-Associated Rhabdomyolysis Without Neuroleptic Malignant Syndrome	3
Tardive Dyskinesia Suppressed With Ginkgo Biloba	3
Reply to “All Patients With Catatonia Deserve Proper Diagnosis, Theragnosis, and Prognosis”	3
The Impact of Once Daily Dosing on Protein Binding of Clozapine and Norclozapine	3
Critical Lithium Level in a Nontoxic Outpatient	3
Characteristics of Ongoing Clinical Trials of Psychogenic Substances for Psychiatric Disorders	3
Second-Generation Antipsychotic Long-Acting Injection Reduced the Time of Restrictive Interventions in Patients With Schizophrenia	3
Recurrent Guaifenesin-Associated Nephrolithiasis Complicates Dextromethorphan Abuse	3
Growing Concerns Over Valproate Teratogenicity Present an Opportunity for Lithium	3
Pramipexole as an Augmentation Strategy to Electroconvulsive Therapy in the Treatment of Bipolar Depression Complicated With Parkinsonism	3
Fifty-Nine-Year-Old Woman With Concurrent Administration of Cobicistat and Dexamethasone Potentially Leading to Mania	2
Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series	2
Semaglutide-Mediated Lithium Toxicity	2
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I	2
Risk of Neutropenia Associated With Duloxetine	2
Question	2
Modafinil Use in an Adolescent With Major Depressive Disorder	2
Obesity Associated With Symptomatic Remission in Clozapine-Treated Individuals With Treatment-Resistant Schizophrenia	2
The Rise and Fall of the Age of Psychopharmacology	2
Critical Feedback on Article by Lee and Colleagues: “Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia”	2
Serotonin Synthesis Amplification to Augment the Therapeutic Efficacy of Serotonin Reuptake Inhibitor Antidepressants	2
Effects of Adjunctive Brexpiprazole in Major Depressive Disorder Analyzed by Baseline Anxiety Level	2
Variability in Response to Antidepressants	2
The Impact of Antidepressant Medications on Sleep in Children	2
Painful Ejaculation Associated With Atomoxetine and Bupropion	2
Group-Based Trajectory Modeling to Identify Patterns of Antipsychotic-Associated Weight Gain Among Children and Adolescents	2
Effect of Coffee and Chocolate Ingestion on Clozapine Dose and on Plasma Clozapine and Norclozapine Concentrations in Clinical Practice	2
κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine	2
Acute Psychosis After Immunization With Whole-Virion Inactivated COVID-19 Vaccine; A Case Report From Central India	2
Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics	2
Metabolic Problems Among People With Treatment-Resistant Schizophrenia are Not Unique to Clozapine	2
Severe Urinary Retention Associated With Combined Treatment With Escitalopram and Quetiapine	2
Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder	2
Cariprazine-Associated Obsessive-Compulsive Symptoms in a Patient With Bipolar Disorder	2
Evaluating the Effectiveness of Cyproheptadine on Acute Neuroleptic-induced Akathisia	2
Lemborexant Attenuates Methamphetamine Craving and Euphoria	2
Adverse Reactions to Clozapine	2
The Use of Classic Psychedelics for Depressive and Anxiety-Spectrum Disorders	2
Fact Versus Fear	2
Blepharospasm Arising From Escitalopram Use	2
Hypotension and Peripheral Edema With Moclobemide	2
Sleep-wake Disorders	2
Zuranolone Concentrations in the Breast Milk of Healthy, Lactating Individuals	2
A Call for the Study of Zuranolone as a Novel Treatment for Premenstrual Dysphoric Disorder	2
Levodopa Augmentation of Antipsychotics for Persistent Negative Symptoms in Schizophrenia	2
Beyond Clozapine	2
Clozapine-Associated Eosinophilia at a Movement Disorders Clinic	2
Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination	2
Advancing the Development of New Medications to Treat Psychiatric Illness	2
Response of Gambling Disorder to Semaglutide	2
Evaluation and Comparison of the Effectiveness of Atropine Eye Drops, Ipratropium Bromide Nasal Spray, and Amitriptyline Tablet in the Management of Clozapine-Associated Sialorrhea in Patients With Re	2
Impact of a Caffeine Restriction Policy on Inpatients With Schizophrenia	2
52-Week Open-Label Safety and Tolerability Study of Centanafadine Sustained Release in Adults With Attention-Deficit/Hyperactivity Disorder	2
Challenges With Short-term Use of Intravenous Racemic Ketamine With Psychotherapy for a Hospitalized Patient With Severe Posttraumatic Stress Disorder and Depression	2
Antidepressant Poisoning Trends in Pediatric Intensive Care	2
Clinician Reasons for Stopping Clozapine	2
Statistical Versus Clinical Significance	2
Catatonia Associated With Valbenazine Treatment	2
Current Clinical Psychopharmacology Integrated Practice	2
Effects of Age, Sex, and Comedication on the Plasma Concentrations of Olanzapine in Chinese Patients With Schizophrenia Based on Therapeutic Drug Monitoring Data	2
A Phase 2 Randomized Trial of NBI-1065846 (TAK-041) in Patients With Anhedonia Associated With Major Depressive Disorder	2
Question	2
The Efficacy of Methylphenidate Use in Children Diagnosed With Attention Deficit Hyperactivity Disorder With Emotional Impulsivity Symptoms	2
Lethal Acute Colonic Pseudo-Obstruction in a Patient Using a Combination of Olanzapine and Clozapine	2
Question	2
Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use	2
Antimicrobial Exposure and Risk for Incident Major Depressive Disorder	2
Effectiveness and Tolerability of Lurasidone for Bipolar Types I and II and Other Specified Bipolar Depression	2
Unraveling the Optimal Treatment Approach for Depression in Schizophrenia Spectrum	2
Prebiotic Treatment in People With Schizophrenia	2
Effects of Adjunctive Brexpiprazole on Individual Depressive Symptoms and Functioning in Patients With Major Depressive Disorder and Anxious Distress	2
Question	2
Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder	2
Comparison of Extrapyramidal Symptoms Among Outpatients With Schizophrenia on Long-Acting Injectable Antipsychotics	2
The Synergistic Effect of Bupropion-Dextromethorphan With Thyroid Supplementation in Treatment-Resistant Depression	2
Question	2
Pimavanserin Exposure-Response Analyses in Patients With Schizophrenia	2
Agomelatine as an Effective Intervention for Psychiatric Symptoms in Postacute Sequelae of COVID-19	2